Cargando…

Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation

PURPOSE: The sensitivity of [(18)F] fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET/CT) for detecting hepatocellular carcinoma (HCC) has not been clarified thoroughly. Our study seeks to explore the association between the Ki-67 index and FDG-avidity in HCC tumors...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Yuping, Liu, Jiachen, Sun, Runlu, Liu, Xuming, Zhou, Zhangchi, Zhang, Hong, Li, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556170/
https://www.ncbi.nlm.nih.gov/pubmed/37682282
http://dx.doi.org/10.1007/s00261-023-04027-4
_version_ 1785116822261989376
author Yin, Yuping
Liu, Jiachen
Sun, Runlu
Liu, Xuming
Zhou, Zhangchi
Zhang, Hong
Li, Dan
author_facet Yin, Yuping
Liu, Jiachen
Sun, Runlu
Liu, Xuming
Zhou, Zhangchi
Zhang, Hong
Li, Dan
author_sort Yin, Yuping
collection PubMed
description PURPOSE: The sensitivity of [(18)F] fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET/CT) for detecting hepatocellular carcinoma (HCC) has not been clarified thoroughly. Our study seeks to explore the association between the Ki-67 index and FDG-avidity in HCC tumors using (18)F-FDG PET/CT. METHODS: 112 HCC lesions from 109 patients detected by (18)F-FDG PET/CT were included retrospectively between August 2017 and May 2022, comprising 82 lesions in the training cohort and 30 in the validation cohort to simulate prospective studies. In the training cohort, lesions were stratified by a lesion-to-liver maximum standardized uptake value (SUV(max)) ratio cut-off of 1.59. The relationships between lesion-to-liver SUV(max) ratios and several clinical factors including tumor differentiation, alpha fetoprotein (AFP), carcinoembryonic antigen (CEA), hepatitis B virus (HBV) infection, Ki-67 index et al. were assessed. These findings were subsequently validated in the independent validation cohort. RESULTS: In the training cohort, group A1 lesions demonstrated a higher Ki-67 index (%, 40.00 [30.00, 57.50] vs. 10.00 [5.00, 28.75], p<0.001) than group A0, the positive correlation between FDG-avidity and Ki-67 index was revealed by multivariate analysis, OR=1.040, 95% CI of OR [1.004–1.077], p=0.030. The calculated cut-off value was 17.5% using the receiver operating characteristic (ROC) curve, with an area under curve (AUC) of 0.834 and 95% CI [0.742–0.926], p<0.001. These findings were further validated in the independent validation cohort, with similar results (AUC=0.875, 95% CI [0.750–1.000], p<0.001). CONCLUSION: In comparison to tumor differentiation, Ki-67 index demonstrates a stronger association with FDG-avidity in HCC tumors, and when the Ki-67 index exceeds 17.5%, (18)F-FDG PET/CT might serve as a useful indicator for HCC. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-10556170
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-105561702023-10-07 Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation Yin, Yuping Liu, Jiachen Sun, Runlu Liu, Xuming Zhou, Zhangchi Zhang, Hong Li, Dan Abdom Radiol (NY) Hepatobiliary PURPOSE: The sensitivity of [(18)F] fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET/CT) for detecting hepatocellular carcinoma (HCC) has not been clarified thoroughly. Our study seeks to explore the association between the Ki-67 index and FDG-avidity in HCC tumors using (18)F-FDG PET/CT. METHODS: 112 HCC lesions from 109 patients detected by (18)F-FDG PET/CT were included retrospectively between August 2017 and May 2022, comprising 82 lesions in the training cohort and 30 in the validation cohort to simulate prospective studies. In the training cohort, lesions were stratified by a lesion-to-liver maximum standardized uptake value (SUV(max)) ratio cut-off of 1.59. The relationships between lesion-to-liver SUV(max) ratios and several clinical factors including tumor differentiation, alpha fetoprotein (AFP), carcinoembryonic antigen (CEA), hepatitis B virus (HBV) infection, Ki-67 index et al. were assessed. These findings were subsequently validated in the independent validation cohort. RESULTS: In the training cohort, group A1 lesions demonstrated a higher Ki-67 index (%, 40.00 [30.00, 57.50] vs. 10.00 [5.00, 28.75], p<0.001) than group A0, the positive correlation between FDG-avidity and Ki-67 index was revealed by multivariate analysis, OR=1.040, 95% CI of OR [1.004–1.077], p=0.030. The calculated cut-off value was 17.5% using the receiver operating characteristic (ROC) curve, with an area under curve (AUC) of 0.834 and 95% CI [0.742–0.926], p<0.001. These findings were further validated in the independent validation cohort, with similar results (AUC=0.875, 95% CI [0.750–1.000], p<0.001). CONCLUSION: In comparison to tumor differentiation, Ki-67 index demonstrates a stronger association with FDG-avidity in HCC tumors, and when the Ki-67 index exceeds 17.5%, (18)F-FDG PET/CT might serve as a useful indicator for HCC. GRAPHICAL ABSTRACT: [Image: see text] Springer US 2023-09-08 2023 /pmc/articles/PMC10556170/ /pubmed/37682282 http://dx.doi.org/10.1007/s00261-023-04027-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Hepatobiliary
Yin, Yuping
Liu, Jiachen
Sun, Runlu
Liu, Xuming
Zhou, Zhangchi
Zhang, Hong
Li, Dan
Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation
title Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation
title_full Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation
title_fullStr Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation
title_full_unstemmed Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation
title_short Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation
title_sort exploring the efficacy of (18)f-fdg pet/ct in hepatocellular carcinoma diagnosis: role of ki-67 index and tumor differentiation
topic Hepatobiliary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556170/
https://www.ncbi.nlm.nih.gov/pubmed/37682282
http://dx.doi.org/10.1007/s00261-023-04027-4
work_keys_str_mv AT yinyuping exploringtheefficacyof18ffdgpetctinhepatocellularcarcinomadiagnosisroleofki67indexandtumordifferentiation
AT liujiachen exploringtheefficacyof18ffdgpetctinhepatocellularcarcinomadiagnosisroleofki67indexandtumordifferentiation
AT sunrunlu exploringtheefficacyof18ffdgpetctinhepatocellularcarcinomadiagnosisroleofki67indexandtumordifferentiation
AT liuxuming exploringtheefficacyof18ffdgpetctinhepatocellularcarcinomadiagnosisroleofki67indexandtumordifferentiation
AT zhouzhangchi exploringtheefficacyof18ffdgpetctinhepatocellularcarcinomadiagnosisroleofki67indexandtumordifferentiation
AT zhanghong exploringtheefficacyof18ffdgpetctinhepatocellularcarcinomadiagnosisroleofki67indexandtumordifferentiation
AT lidan exploringtheefficacyof18ffdgpetctinhepatocellularcarcinomadiagnosisroleofki67indexandtumordifferentiation